3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Testicular Germ Cell Tumor
1
Sarcoma
1
Ovarian Neoplasms
1
Breast Neoplasms
1
Interventions
Specimen Handling
27
Magnetic Resonance Spectroscopy
23
Cyclophosphamide
16
Biopsy
16
Doxorubicin
13
pembrolizumab
11
Temozolomide
11
X-Rays
10
Radiation
10
atezolizumab
8
Radiotherapy
8
Irinotecan
8
Phantoms, Imaging
7
Nivolumab
7
fludarabine
6
Vincristine
6
Immunoglobulin G
6
Etoposide
6
Bevacizumab
6
liposomal doxorubicin
5
cemiplimab
5
cabozantinib
5
Sirolimus
5
Ifosfamide
5
Gemcitabine
5
Disulfides
5
palbociclib
4
olaparib
4
fludarabine phosphate
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypnosis
×
Sarcoma
×
30 days
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled